Long-Term Liabilities to Equity: IRADIMED Inc. (IRMD)

Official company branding of IRADIMED Inc. (IRMD)

IRADIMED CORPORATION (IRMD) sources components for infusion systems from third-party suppliers while maintaining final assembly in-house. The business also delegates the creation of electronic modules and global logistics to external contractors. This price action shown below, where the indicator stands at 0.00, is complemented by the effective leadership of Roger Susi, who ensures high profitability through exclusive technological solutions in the specialized medical equipment sector.

Iradimed (IRMD): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for IRADIMED CORPORATION (IRMD)

- price and consensus price forecast:
Market Chart IRADIMED Corp|IRMD - Price Target Chart
- market capitalization data:
Market Valuation IRADIMED CORPORATION|IRMD - Enterprise Value
- book capitalization data:
Net Asset Value per Share IRADIMED|IRMD - Book Capitalization|Market Cap to Net Assets Ratio iradimed.com|IRMD - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient IRADIMED CORPORATION|IRMD - Long-Term Debt to Capital|Short-Term Debt to Capital iradimed.com|IRMD - Company Debts|Debt to Book Capitalization Ratio IRADIMED CORPORATION|IRMD - Company Long-Term Debts|Short-Term Debt Volume IRADIMED
Comprehensive company analysis:IRMD, IRADIMED Corp
Core merchandise of IRADIMED CORPORATION

This indicator measures the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial leverage and the business development financing strategy. For IRADIMED CORPORATION (IRMD), which combines in-house assembly with component outsourcing, the long-term debt-to-equity ratio reflects the balance between investments in production capacity and financial autonomy, confirming the overall stability of the company's capital.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital ESTA|BBNX - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio Embecta Corp.|TNDM - Long-Term Liabilities to Equity|Long-Term Debt to Capital AXGN|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)